Recent Reports

ICER’s Evidence Report on treatment for tardive dyskinesia.

View More on this Topic

ICER’s Draft Evidence Report on voretigene neparvovec, open to public comment until December 13, 2017. For more information on submitting a public comment, please visit our stakeholder engagement page.

View More on this Topic

ICER’s final report on acupuncture, cognitive behavioral therapy, mindfulness-based stress reduction, tai chi, and yoga for chronic low back and neck pain.

View More on this Topic

ICER’s report reviewed evidence on ten abuse-deterrent formulations (ADF) of opioids. Nine of the drugs were extended release (ER) opioids, and one was immediate release (IR). The report assessed evidence on how effectively the drugs reduce abuse of opioids at both the individual patient and population levels.

View More on this Topic

Materials

New England CEPAC

Endometriosis: Open Input Period

New England CEPAC

Tardive Dyskinesia: Evidence Presentation

New England CEPAC

Tardive Dyskinesia: Response to Comments

New England CEPAC

Hemophilia A: Model Analysis Plan

New England CEPAC

Hemophilia A: Research Protocol

ICER

Orphan Drug Assessment: Final Framework Adaptations

New England CEPAC

Psoriasis Update: Stakeholder List

New England CEPAC

Psoriasis Update: Draft Scoping Document

CTAF

Migraine: Stakeholder List

CTAF

Migraine: Draft Scoping Document

New England CEPAC

Psoriasis Update: Open Input

CTAF

Migraine: Open Input